tiprankstipranks

Stanley Crooke Insider Profile

4 Followers
Stanley Crooke, Exec Chairman of the Board, Director at Ionis Pharmaceuticals, holds 499.52K shares in Ionis Pharmaceuticals (Ticker: IONS), holds 7.05M shares in Regulus (Ticker: RGLS).
tipranks
Stanley Crooke

Stanley Crooke
Ionis Pharmaceuticals (IONS)
Exec Chairman of the Board, Director

Ranked #41,899 out of 98,909 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

+14.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$34M
56.81%
43.19%
A breakdown of Stanley Crooke's holdings

Insider Roles

Ionis Pharmaceuticals
(IONS)
Exec Chairman of the Board, Director
Regulus
(RGLS)
Director, Ten Percent Owner
Roles that Stanley Crooke holds in companies

Most Profitable Insider Trade

Stock:
Ionis Pharmaceuticals
(IONS)
Rating:Informative Buy
Date:Jan 02, 2014 - Jan 02, 2015
Return:+54.40%
The most profitable trade made by Stanley Crooke

Stanley Crooke's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Ionis Pharmaceuticals
Jan 28, 2021
Exec Chairman of the Board, Director
Uninformative Sell
1.81M
$19.38M
Regulus
Oct 11, 2012
Director, Ten Percent Owner
Uninformative Buy
$14.73M
List of latest transactions for each holding click on a transaction to see Stanley Crooke's performance on stock

Stanley Crooke insider profile FAQ

What is the percentage of profitable transactions made by Stanley Crooke?
The percentage of profitable transactions made by Stanley Crooke is 50%.
    What is the average return per transaction made by Stanley Crooke?
    The average return per transaction made by Stanley Crooke is 14.30%.
      What stocks does Stanley Crooke hold?
      Stanley Crooke holds: IONS, RGLS stocks.
        What was Stanley Crooke’s latest transaction?
        Stanley Crooke latest transaction was an Uninformative Sell of $1.81M.
          What was Stanley Crooke's most profitable transaction?
          Stanley Crooke’s most profitable transaction was an Informative Buy of IONS stock on January 2, 2014. The return on the trade was 54.40%.
            What is Stanley Crooke's role in Ionis Pharmaceuticals?
            Stanley Crooke's role in Ionis Pharmaceuticals is Exec Chairman of the Board, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.